SAFETY OF SGLT2 INHIBITORS (SGLT2I) IN PEOPLE OVER 75 YEARS

被引：0
|
作者：
Marques Vidas, Maria [1 ]
Domenech, Ester [1 ]
Martin Testillano, Lucia [1 ]
Maroto, Alba [1 ]
Lopez, Paula [1 ]
Portoles, Jose' M. [1 ]
机构：
[1] Puerta de Hierro Univ Hosp, Dept Nephrol, Majadahonda, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO167
引用
收藏
页码：I104 / I104
页数：1
相关论文
共 50 条
  • [41] Multiple Effects of SGLT2 Inhibitors
    Nagasu, Hajime
    JMA JOURNAL, 2024, 7 (04): : 580 - 581
  • [42] SGLT2 Inhibitors and Renal Function
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1499): : 91 - 92
  • [43] SGLT2 inhibitors in clinical practice
    Ryden, Lars
    Norhammar, Anna
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (07): : 434 - 435
  • [44] SGLT2 Inhibitors and the Diabetic Kidney
    Fioretto, Paola
    Zambon, Alberto
    Rossato, Marco
    Busetto, Luca
    Vettor, Roberto
    DIABETES CARE, 2016, 39 : S165 - S171
  • [45] Cancer: Repurposing SGLT2 inhibitors
    Crunkhorn S.
    Nature Reviews Drug Discovery, 2019, 18 (1) : 18 - 18
  • [46] Chances and risks of SGLT2 inhibitors
    Peter Mayer
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385 : 551 - 554
  • [47] SGLT2 Inhibitors in Liver Patients
    Hsiang, John Chen
    Wong, Vincent Wai-Sun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (10) : 2168 - +
  • [48] SGLT2 inhibitors: β blockers for the kidney?
    Gilbert, Richard E.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (10): : 814 - 814
  • [49] SGLT2 inhibitors and autophagy in diabetes
    Yaribeygi, Habib
    Maleki, Mina
    Atkin, Stephen L.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (04) : 392 - 398
  • [50] Benefits of SGLT2 inhibitors in arrhythmias
    Gao, Jinghan
    Xue, Genlong
    Zhan, Ge
    Wang, Xinying
    Li, Jiatian
    Yang, Xiaolei
    Xia, Yunlong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345